The studies in human cervical cancer indicated that poorer clinical outcomes, such as larger tumor size and elevated lymph node metastasis, are correlated with STIM1 upregulation in primary tumors [184], highlighting the clinical significance of STIM1 in cervical cancer progression. This evidence concerns the gene STIM1 and cervical cancer.